Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06263322 · ClinicalTrials.gov registry record · NA
The ROAMM-EHR Study
A NA study of Peripheral Arterial Disease and Chronic Limb-Threatening Ischemia, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06263322 is a NA study of Peripheral Arterial Disease and Chronic Limb-Threatening Ischemia that is actively recruiting participants, run by University of Florida. The registered enrollment target is 50 participants, below the 4,206-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06263322, a NA study of Peripheral Arterial Disease and Chronic Limb-Threatening Ischemia, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
In recent years, mobile health (mHealth) apps have promised improved monitoring of health conditions to improve clinical outcomes. The objective of this study is to conduct a pilot randomized clinical trial (RCT) to evaluate the impact of using remotely collected patient generated health data (PGHD) from older patients undergoing bypass surgery due to chronic limb threatening ischemia. The hypothesis is that integrating PGHD with an EHR system will help providers manage post-surgical symptoms and thus improve post-operative mobility and quality of life health outcomes.
Conditions Studied
Interventions
- BEHAVIORAL Actionable remotely generated health data
- BEHAVIORAL Non-Actionable remotely generated health data
Study Locations (1)
Florida
- Institute of Aging - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-11-16 |
| Est. Completion | 2026-10-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06263322
The ClinicalTrials.gov registry entry for NCT06263322 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,206-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 2 interventions - of which Actionable remotely generated health data is the first listed.
NCT06263322 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06263322 about?
NCT06263322 is a clinical study titled "The ROAMM-EHR Study". In recent years, mobile health (mHealth) apps have promised improved monitoring of health conditions to improve clinical outcomes. The objective of this study is to conduct a pilot randomized clinical trial (RCT) to evaluate the impact of using remotely collected patient generated health data (PGHD)...
What is the current status of trial NCT06263322?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-11-16. Estimated completion is 2026-10-17.
What conditions does trial NCT06263322 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia.
What interventions are being tested in trial NCT06263322?
The interventions under investigation include: Actionable remotely generated health data (BEHAVIORAL), Non-Actionable remotely generated health data (BEHAVIORAL).
Who is sponsoring clinical trial NCT06263322?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06263322 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
-
Prehabilitation and Rehabilitation in PAD
RECRUITING · NA
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
Assessment of the Utility of the Pantheris Small Vessel (SV) System
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.